Drug Target Review2025-02-27T09:00:18
Researchers have identified a small gene, SCN10a-short, that could enable gene therapy to treat malignant cardiac arrhythmias. This discovery offers the potential for a one-time treatment, reducing the reliance on lifelong medication and invasive procedures.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-07-31T06:00:00Z
Contributor Dr Davinder Ramsingh, Drug Target Review
2025-03-19T15:00:00
Sponsored by Eurofins DiscoverX
2024-05-07T13:11:19
Sponsored by BellBrook Labs
2026-07-10T06:15:00
Contributor Professor Donald E Ingber, Drug Target Review
2023-11-20T13:43:43
Sponsored by Merck
2025-11-19T16:00:00
Sponsored by Eurofins DiscoverX
2026-07-01T13:30:00
Contributor Carrie Maynard and Dr Veronica Fowler
Site powered by Webvision Cloud